Diabetes Mellitus

Diabetes Medication Satisfaction (DiabMedSat)

Copyright: Novo Nordisk

Disease / Condition: diabetes mellitus

Population, Age: adult

Type of Clinical Outcome Assessment: PRO measure

Outcome assessed: treatment satisfaction

  • Domains (n=3): Efficacy, Symptoms, Burden
    Number of items: 21
    Recall: past two weeks
    Language of Development: English for USA

    1. Brod, M., Skovlund, S.E., Wittrup-Jensen, K. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res. 2006 Apr;15(3):481-491.

    2. Brod M, Christensen T, Kongsø JH, Bushnell DM. Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure. J Med Econ. 2009;12(4):309-16. doi: 10.3111/13696990903337017.

  • Contact Mapi Research Trust.

For more information on this measure, for use and/or licensing, contact Mapi Research Trust.

Diabetes Pen Experience Measure (DPEM)

Copyright: Novo Nordisk

Disease / Condition: diabetes mellitus

Population, Age: adult

Type of Clinical Outcome Assessment: PRO measure to evaluate the respondents' experience with diabetes injection devices.

Outcome assessed: overall pen use

  • Domains (n=1): DPEM Total Score
    Number of items: 7
    Recall: current
    Language of Development: English for USA

  • Brod M, Tesler Waldman L, Sparre T, Busk AK. Development and Validation of the Diabetes Pen Experience Measure: A New Patient-Reported Outcome Measure. J Diabetes Sci Tech. 2023 May;17(3):705-714. doi: 10.1177/19322968221079396.

  • Contact Mapi Research Trust.

For more information on this measure, for use and/or licensing, contact Mapi Research Trust.

Diabetes Productivity Measure (DPM)

Copyright: Novo Nordisk

Disease / Condition: diabetes mellitus

Population, Age: adult

Type of Clinical Outcome Assessment: PRO measure

Outcome assessed: productivity impairment in patients with diabetes mellitus

  • Domains (n=2): Life productivity, Work productivity
    Number of items: 14 items
    Recall: past two weeks
    Language of Development: English for USA

  • Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res. 2006 Apr;15(3):481-91

  • Contact Mapi Research Trust.

For more information on this measure, for use and/or licensing, contact Mapi Research Trust.

Diabetes Symptom Measure (DSM)

Copyright: Novo Nordisk

Disease / Condition: diabetes mellitus

Population, Age: adult

Type of Clinical Outcome Assessment: PRO measure

Outcome assessed: symptoms

  • Domains (n=1): symptoms
    Number of items: 30
    Recall: last two weeks
    Language of Development: English for USA

    1. Brod, M., Skovlund, S.E., Wittrup-Jensen, K. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res. 2006 Apr;15(3):481-491.

  • Contact Mapi Research Trust.

For more information on this measure, for use and/or licensing, contact Mapi Research Trust.

Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure

Copyright: Mery Brod, The Brod Group

Disease / Condition: diabetic mellitus; diabetic peripheral neuropathic pain

Population, Age: adult

Type of Clinical Outcome Assessment: PRO measure to assess the impact of diabetic peripheral neuropathic pain.

Outcome assessed: health-related quality of life

  • Domains (n=3): physical functioning/mobility, sleep, and daily activities
    Number of items: 18
    Recall: over the past week
    Language of Development: English for USA

  • Brod M, Blum SI, Bushnell DM, Ramasamy A. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure. Qual Life Res. 2015 Dec;24(12):3001-14

  • Arabic-Israel
    Chinese-Chinese
    Czech-Czech Republic
    Dutch-Belgium
    Dutch-Netherlands
    English-Canada
    French-Belgium
    French-Canada
    French-France
    German-Austria
    German-Germany - forthcoming
    Hebrew-Israel
    Hindi-India
    Hungarian-Hungary
    Italian-Italy
    Korean-South Korean
    Marathi-India
    Portuguese-Brazil
    Romanian-Romania
    Russian-Israel
    Russian-Ukraine
    Slovak-Slovakia
    Spanish-Argentina - forthcoming
    Spanish-Mexico - forthcoming
    Spanish-Puerto Rico
    Spanish-Spain
    Spanish-US
    Urkainian-Ukraine

For more information on this measure, for use and/or licensing, contact Dr. Brod at (+1) 415 381 5532 or at mbrod@thebrodgroup.net or by filling out the CONTACT FORM.

Treatment Related Impact Measure - Hypoglycaemic Events (TRIM-HYPO)

Copyright: Novo Nordisk

Disease / Condition: diabetes mellitus

Population, Age: adult

Type of Clinical Outcome Assessment: PRO measure

Outcome assessed: impact of non-severe hypoglycemic events on the daily functioning and quality of life of individuals with diabetes

  • Domains (n=5): Daily functioning, Emotional well-being, Diabetes management, Sleep disruption, Work productivity
    Number of items: 33
    Recall: past 30 days
    Language of Development: English for USA

    1. Brod, M., Hojbjerre, L., Bushnell, D.M., Hansen, C.T. Assessing the impact of non-severe hypoglycemic events and treatment in adults: Development of the Treatment-Related Impact Measure-Non-severe Hypoglycemic Events (TRIM-HYPO). Qual Life Res. 2015;24(12):2971-84. doi:10.1007/s11136-015-1023-6.

  • Contact Mapi Research Trust.

For more information on this measure, for use and/or licensing, contact Mapi Research Trust.

Treatment Related Impact Measure for Diabetes (TRIM-D)

Copyright: Novo Nordisk

Disease / Condition: diabetes mellitus

Population, Age: adult

Type of Clinical Outcome Assessment: PRO measure

Outcome assessed: treatment burden

  • Domains (n=5): Treatment Burden, Daily Life, Diabetes Management, Compliance and Psychological Health
    Number of items: 28
    Recall: past two weeks
    Language of Development: English for USA

  • 1.. Brod, M., Hammer, M., Christensen, T., Lessard, S., Bushnell, D.M. Understanding and assessing the impact of treatment in diabetes: The Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device). Health Qual Life Outcomes. 2009 Sep 9;7:83.

    2. Brod, M., Christensen, T., Hammer, M., Busk, A.K., Bushnell, D.M. Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures. Qual Life Res. 2011 Nov;20(9):1513-1518.Description text goes here

  • Contact Mapi Research Trust.

For more information on this measure, for use and/or licensing, contact Mapi Research Trust.

Treatment Related Impact Measure for Diabetes Device (TRIM-DD)

Copyright: Novo Nordisk

Disease / Condition: diabetes mellitus

Population, Age: adult

Type of Clinical Outcome Assessment: PRO measure

Outcome assessed: treatment burden, diabetes devices

  • Domains (n=2): Device Bother and Device Function
    Number of items: 8
    Recall: past two weeks
    Language of Development: English for USA

  • 1.. Brod, M., Hammer, M., Christensen, T., Lessard, S., Bushnell, D.M. Understanding and assessing the impact of treatment in diabetes: The Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device). Health Qual Life Outcomes. 2009 Sep 9;7:83.

    2. Brod, M., Christensen, T., Hammer, M., Busk, A.K., Bushnell, D.M. Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures. Qual Life Res. 2011 Nov;20(9):1513-1518.

  • Contact Mapi Research Trust.

For more information on this measure, for use and/or licensing, contact Mapi Research Trust.